This session delved deep into the nuances of artificial intelligence (AI) regulation and its impact on medical devices. The session speakers explored and compared the legislative frameworks, specifically focusing on the EU Artificial Intelligence Act (the AI Act) but also mentioning the various approaches taken in the US
The AI Act, Regulation (EU) 2024/1689, lays down harmonised rules on artificial intelligence. Its aim is to regulate the ethical use of AI and provide AI developers with clear requirements and obligations regarding specific uses of AI. The Act, which was published on 12 July 2024 and will be fully implemented by August 2027, aims to ensure that AI systems are safe, respect fundamental rights, foster AI investment, improve governance and encourage a harmonised single EU market for AI
To read more key points and the session summary, log in as a member or register for free using the links below.
How to read this journal article
Thank you for visiting Regulatory Rapporteur. Journal articles are restricted to TOPRA members and registered users.
If you are a TOPRA member, or have already registered for limited free access, log in now (Option 1 below).
Not yet a member? You can either join TOPRA (Option 2 below) or register to view limited content for free (Option 3 below).
1. LOGIN
Already a TOPRA member?
Log in now using your MyTOPRA credentials, for unlimited access to all Regulatory Rapporteur journal articles, the online archive and latest industry news and podcasts.
Already registered for free content?
If you are not a TOPRA member but have already created an account to access limited free content, log in here using your registered user email and password.